Kurowski M
Institut für Pharmakologie und Toxikologie, Friedrich-Alexander-Universität Erlangen-Nürnberg.
Z Rheumatol. 1988 May-Jun;47(3):173-6.
The transsynovial distribution and tissue accumulation of tiaprofenic acid (Surgam)--a nonsteroidal anti-inflammatory agent--was studied in 55 patients scheduled for knee joint surgery. The patients suffering from rheumatoid arthritis (53), ankylosing spondylitis (1) or a chronicly irritated knee joint (1), received 300 mg of tiaprofenic acid b.i.d. starting 4 days prior to surgery. Samples of plasma, synovial fluid, fat, muscle, bone and synovial tissue were obtained simultaneously at defined times following the last dose. The samples were analyzed for tiaprofenic acid employing HPLC. Peak plasma concentrations of 28.6 micrograms/ml were achieved after 1 h, whereas synovial levels rose up to 2.8 micrograms/ml after 8 h. The time course of the concentration ratios indicates equilibration of both compartments 6 h following the last dose. Elimination occurs with half-lives of 1.9 h from plasma and 3.1 h from synovial fluid. During this period, synovial levels persist in a range sufficient for in vitro cyclooxygenase inhibition. In contrast, tiaprofenic acid does not exert marked tissue affinity, probably due to its hydrophilic properties.
在55例计划进行膝关节手术的患者中,研究了非甾体抗炎药噻洛芬酸(舒雅美)的经滑膜分布及组织蓄积情况。患有类风湿性关节炎(53例)、强直性脊柱炎(1例)或膝关节慢性炎症(1例)的患者,在手术前4天开始每天两次服用300mg噻洛芬酸。在最后一剂给药后的特定时间同时采集血浆、滑液、脂肪、肌肉、骨骼和滑膜组织样本。采用高效液相色谱法分析样本中的噻洛芬酸。1小时后血浆峰浓度达到28.6微克/毫升,而滑液水平在8小时后升至2.8微克/毫升。浓度比的时间进程表明最后一剂给药后6小时两个腔室达到平衡。消除半衰期血浆为1.9小时,滑液为3.1小时。在此期间,滑液水平维持在足以抑制体外环氧化酶的范围内。相比之下,噻洛芬酸可能因其亲水性而没有明显的组织亲和力。